- Chronic Diseases / Disorders
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Quality of Life
Endovenous Ablation Interventions for Symptomatic Varicose Veins of the Legs
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP).
This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose veins of the legs due to venous reflux in working age patients when compared to conventional open surgery.
It also describes the nature varicose veins with venous reflux, the available clinical practice guidelines regarding the management of the condition, as well as the technologies currently being delivered in Alberta to treat the condition and the available system capacity for delivery of the technologies being assessed.
- Section One – Social and System Demographics: Ken Bond, Christa Harstall, Liz Dennett
- Section Two – Technology Efficacy and Effectiveness: Paula Corabian; Ken Bond, Christa Harstall, Liz Dennett
- Section Three – Economic Analysis: Charles Yan, Ken Bond, Anderson Chuck, Liz Dennett
- Information Specialist: Liz Dennett
Health Technology Assessments /
Year of Publication: 2014
Topics: Health Economics / Healthcare Costs, Quality of Life, Therapy
Authors: IHE Institute of Health Economics
ISBN (online): 978-1-926929-23-1